CD274 and neoplasm: Besides, PDT or chemotherapy related adaptive immune resistance caused by the up-expression of PD-L1 in tumor cells can be abolished by incorporating anti-PD-L1 monoclonal antibodies into the treatment strategy [13, 23, 24, 45, 46].